{"paper_id":"eede7232-9c85-4c9c-b063-e53f4a94d7ab","body_text":"Abstract\nImpaired endometrial receptivity is an important contributing factor to implantation failure. Uterine leiomyomas are widely prevalent steroid hormone–dependent benign tumors that act as a restraint to conception and successful outcome of pregnancies. Reports are available, which suggest that leiomyomas have negative influence on endometrial receptivity to blastocyst implantation. The aim of the present review is to provide a comprehensive picture of the current knowledge of the effect of uterine leiomyomas on the architectural, cellular, and molecular determinants of endometrial receptivity. Understanding the potential role of these factors will provide insight into the underlying mechanisms of leiomyoma-associated infertility and provide new areas for basic and translational research.\nSimilar content being viewed by others\nReferences\nMakker A, Singh MM. Endometrial receptivity Clinical assessment in relation to fertility, infertility and infertility. Med Res Rev 2006;26 6: 699–746.\nBergh PA, Navot D. The impact of embryonic development and endometrial maturity on the timing of implantation. Fertil Steril 1992;58 3: 537–542.\nRashid NA, Lalitkumar S, Lalitkumar PG, Gemzell-Danielsson K. Endometrial receptivity and human embryo implantation. Am J Reprod Immunol. 2011;66(suppl 1):23–30.\nSimon C, Moreno C, Remohi J, Pellicer A. Cytokines and embryo implantation. J Reprod Immunol. 1998;39(1–2):117–131.\nMakker A, Goel MM, Das V, Agarwal A. PI3K-Akt-mTOR and MAPK signaling pathways in polycystic ovarian syndrome, uterine leiomyomas and endometriosis: an update. Gynecol Endocrinol. 2012;28(3):175–181.\nStovall DW, Parrish SB, Van Voorhis BJ, Hahn SJ, Sparks AE, Syrop CH. Uteine leiomyomas reduce the efficacy of assisted reproduction cycles: results of a matched follow-up study. Hum Reprod. 1998;13(1):192–197.\nEldar-Geva T, Meagher S, Healy DL, MacLachlan V, Breheny S, Wood C. Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment. Fertil Steril. 1998;70(4):687–691.\nSurrey ES, Lietz AK, Schoolcraft WB. Impact of intramural leiomyomata in patients with a normal endometrial cavity on in vitro fertilization-embryo transfer cycle outcome. Fertil Steril. 2001;75(2):405–410.\nRichards PA, Richards PD, Tiltman AJ. The ultrastructure of fibromyomatous myometrium and its relationship to infertility. Hum Reprod Update 1998;4(5): 520–525.\nOlive DL, Pritts EA. Fibroids and reproduction. Semin Reprod Med. 2010;28(3):218–227.\nOliveira FG, Abdelmassih VG, Diamond MP, Dozortsev D, Melo NR, Abdelmassih R. Impact of subserosal and intramural uterine fibroids that do not distort the endometrial cavity on the outcome of in vitro fertilization intracytoplasmic injection. Fertil Steril 2004;81 3: 582–587.\nMatsuzaki S, Canis M, Darcha C, Pouly JL, Mage G. HOXA-10 expression in the mid-secretory endometrium of infertile patients with either endometriosis, uterine fibromas or unexplained infertility. Hum Reprod. 2009;24(12):3180–3187.\nRackow BW, Taylor HS. Submucosal uterine leiomyomas have a global effect on molecular determinants of endometrial receptivity. Fertil Steril. 2010;93(6):2027–2034.\nFarrer-Brown G, Beilby JO, Tarbit MH. Venous changes in the endometrium of myomatous uteri. Obstet Gynecol. 1971;38(5):743–751.\nPatterson-Keels LM, Selvaggi SM, Haefner HK, Randolph JF Jr. Morphologic assessment of endometrium overlying submucosal leiomyomas. J Reprod Med. 1994;39(8):579–584.\nHorcajadas JA, Goyri E, Higo’n M A, et al. Endometrial receptivity and implantation are not affected by the presence of uterine intramural leiomyomas: a clinical and functional genomics analysis. J Clin Endocrinol Metab. 2008;93(9):3490–3498.\nNoyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Fertil Steril. 1950;1:3–17.\nYoshino O, Hayashi T, Osuga Y, et al. Decreased pregnancy rate is linked to abnormal uterine peristalsis caused by intramural fibroids. Hum Reprod. 2010;25(10):2475–2479.\nNalaboff KM, Pellerito JS, Ben-Levi E. Imaging the endometrium: disease and normal variants. Radiographics. 2001;21(6):1409–1424.\nLevens ED, Stegman BJ, Feinberg EC, Larsen FW. Ultrasongraphic characteristic of the endometrium among patients with fibroids undergoing ART. Fertil Steril. 2008;89(4):1005–1007.\nDietterich C, Check JH, Choe JK, Nazari A, Lurie D. Increased endometrial thickness on the day of human chorionic gonadotropin injection does not adversely affect pregnancy or implantation rates following in vitro fertilization-embryo transfer. Fertil Steril 2002;77 4: 781–786.\nZhang X, Chen CH, Confino E, Barnes R, Milad M, Kazer RR. Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization embryo transfer. Fertil Steril. 2005;83(2):336–340.\nSharara FI, Lim J, McClamrock HD. Endometrial pattern on the day of oocyte retrieval is more predictive of implantation success than the pattern or thickness on the day of hCG administration. J Assist Reprod Genet. 1999;16(10):523–528.\nCoulam CB, Stern JJ, Soenksen DM, Britten S, Bustillo M. Comparison of pulsatility indices on the day of oocyte retrieval and embryo transfer. Hum Reprod. 1995;10(1):82–84.\nJinno M, Ozaki T, Iwashita M, Nakamura Y, Kudo A, Hirano H. Measurement of endometrial tissue blood flow: a novel way to assess uterine receptivity for implantation. Fertil Steril. 2001; 76(6):1168–1174.\nKurjak A, kupesic-Urek S, Miric D. The assessment of benign uterine tumor vascularization by transvaginal color Doppler. Ultrasound Med Biol 1992;18 7: 645–649.\nSladkevicius P, Valentin L, Marsal K. Transvaginal Doppler examination of uteri with myomas. J Clin Ultrasound. 1996;24:135–140.\nNg EHY, Ho PC. Doppler ultrasound examination of uterine arteries on the day of oocyte retrieval in patients with uterine fibroids undergoing in vitro fertilization treatment. Hum Reprod 2002;17(3): 765–770.\nNg EHY, Chan CCW, Tang OS, Yeung WSB, Ho PC. Endometrial and subendometrial blood flow measured by three-dimensional power Doppler ultrasound in patients with small intramural uterine fibroids during IVF treatment. Hum Reprod 2005;20 2: 501–506.\nHershkovitz R, Sheiner E, Mazor M. Ultrasound in obstetrics: a review of safety. Eur J Obstet Gynecol Reprod Biol. 2002;101(1):15–18.\nNg EHY, Chan CCW, Tang OS, Yeung WSB, Ho PC. Endometrial and subendometrial blood flow measured during early luteal phase by three-dimensional power Doppler ultrasound in excessive ovarian responders. Hum Reprod. 2004;19(4):924–931.\nPollheimer J, Knofler M. Signalling pathways regulating the invasive differentiation of human trophoblasts: a review. Placenta. 2005;26(suppl A):S21–S30.\nGentilini D, Busacca M, Di Francesco S, Vignali M, Vigano P, Di Blasio AM. PI3K/Akt and ERK1/2 signalling pathways are involved in endometrial cell migration induced by 17b-estradiol and growth factors. Mol Hum Reprod. 2007;13(5):317–322.\nShokrzadeh N, Alizadeh Z. Semi-quantitative analysis of endometrial receptivity marker mRNA expression in the midsecretory endometrium of patients with uterine fibromas. African J Biotech. 2012;11:6220–6225.\nMarsh EE, Bulun SE. Steroid hormones and leiomyomas. Obstet Gynecol Clin North Am. 2006;33(1):59–67.\nButtram VC Jr. Uterine leiomyomata-aetiology, symptomatology, and management. Prog Clin Biol Res. 1986;225:275–296.\nJakimiuk AJ, Bogusiewicz M, Tarkowski R, et al. Estrogen receptor a and β expression in uterine leiomyomas from premenopausal women. Fertil Steril. 2004;82(suppl 3):1244–1249.\nValladares F, Frías I, Báez D, et al. Characterization of estrogen receptors alpha and beta in uterine leiomyoma cells. Fertil Steril 2006;86 6: 1736–1743.\nBakas P, Liapis A, Vlahopoulos S, et al. Estrogen receptor α and β in uterine fibroids: a basis for altered estrogen responsiveness. Fertil Steril. 2008;90(5):1878–1885.\nWei T, Geiser AG, Qian HR, et al. DNA microarray data integration by ortholog gene analysis reveals potential molecular mechanisms of estrogen-dependent growth of human uterine fibroids. BMC Women’s Health. 2007;7:5.\nHassan MH, Salama SA, Arafa HMM, Hamada FMA, Al-Hendy A. Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen and progesterone regulated gene expression. J Clin Endocrinol Metab. 2007;92(10):3949–3957.\nWilkens J, Critchley H. Progesterone receptor modulators in gynaecological practice. J Fam Plann Reprod Health Care 2010;36 2: 87–92.\nToyofuku A, Hara T, Taguchi T, Katsura Y, Ohama K, Kudo Y. Cyclic and characteristic expression of phosphorylated Akt in human endometrium and decidual cells in vivo and in vitro. Hum Reprod. 2006;21(5):1122–1128.\nCastro A, Johnson MC, Anido M, Cortinez A, Gabler F, Vega M. Role of nitric oxide and bcl-2 family genes in the regulation of human endometrial apoptosis. Fertil Steril. 2002;78(3):587–595.\nLi A, Felix JC, Hao J, Minoo P, Jain JK. Menstrual like breakdown and apoptosis in human endometrial explants. Hum Reprod 2005;20 6: 1709–1719.\nBanerjee P, Sapru K, Strakova Z, Fazleabas AT. Chorionic gonadotropin regulates prostaglandin E synthase via a phosphatidylinositol 3-kinase-extracellular regulatory kinase pathway in human endometrial epithelial cell line: implications for endometrial responses for embryo implantation. Endocrinology. 2009;150(9):4326–4337.\nKang JL, Wang DY, Wang XX, Yu J. Up-regulation of apoptosis by gonadotrophin-releasing hormone agonist in cultures of endometrial cells from women with symptomatic myomas. Hum Reprod. 2010;25(9):2270–2275.\nSinclair DC, Mastroyannis A, Taylor HS. Leiomyoma simultaneously impair endometrial BMP-2-mediated decidualization and anticoagulant expression through secretion of TGF-β3. J Clin Endocrinol Metab. 2011;96(2):412–421.\nBen-Nagi J, Miell J, Mavrelos D, Naftalin J, Lee C, Jurkovic D. Endometrial implantation factors in women with submucous uterine fibroids. Reprod Biomed Online. 2010;21(5):610–615.\nKabir-Salmani M, Hosseini A, Valojerdi MR. Endometrial receptivity to implantation in humans: biochemical and molecular aspects. Yakhteh Med J. 2008;10(1):1–24.\nMohamed OA, Jonnaert M, Labelle-Dumais C, Kuroda K, Clarke HJ, Dufort DM. Uterine Wnt/β-catenin signaling is required for implantation. Proc Natl Acad Sci U S A. 2005;102(24):8579–8584.\nTulac S, Overgaard HT, Hamilton AE, Jumbe NL, Suchanek E, Giudice LC. Dickkopf-1, an inhibitor of Wnt signaling, is regulated by progesterone in human endometrial stromal cells. J Clin Endocrinol Metab. 2006;91(4):1453–1461.\nLi LJ, Zhang JV, Cao YJ, et al. Inhibition of the β-catenin signaling pathway in blastocyst and uterus during the window of implantation in mice. Biol Reprod. 2005;72(3):700–706.\nSatterfield MC, Dunlap KA, Hayashi K, Burghardt RC, Spencer TE, Bazer FW. Tight and adherens junctions in the ovine uterus: differential regulation by pregnancy and progesterone. Endocrinology. 2007;148(8):3922–3931.\nRahnama F, Thompson B, Steiner M, Shafiei F, Lobie PE, Mitchell MD. Epigenetic regulation of E-cadherin controls endometrial receptivity. Endocrinology. 2009;150(3):1466–1472.\nMatsuzaki S, Darcha C, Maleysson E, Canis M, Mage G. Impaired down-regulation of E-cadherin and β-catenin protein expression in endometrial epithelial cells in the mid-secretory endometrium of infertile patients with endometriosis. J Clin Endocrinol Metab. 2010;95(7):3437–3445.\nMunro SK, Farquahar CM, Mitchell MD, Ponnampalam AP. Epigenetic regulation of endometrium during the menstrual cycle. Mol Hum Reprod. 2010;16(5):297–310.\nAu CL, Rogers PA. Immunohistochemical staining of von Willebrand factor in human endometrium during normal menstrual cycle. Hum Reprod. 1993;8(1):17–23.\nHague S, Zhang L, Oehler MK, et al. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density. Clin Cancer Res. 2000;6(7):2808–2814.\nMangrulkar RS, Ono M, Ishikawa M, Takashima S, Klagsbrun M, Nowak RA. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium. Biol Reprod. 1995;53(3):636–646.\nLiu YX, Gao F, Wei P, et al. Involvement of molecules related to angiogenesis, proteolysis and apoptosis in implantation in rhesus monkey and mouse. Contraception. 2005;71(4):249–262.\nAnania CA, Stewart EA, Quade BJ, Hill JA, Nowak RA. Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding. Mol Hum Reprod. 1997;3(8):685–691.\nQuenby S, Farquharson R. Uterine natural killer cells, implantation failure and recurrent miscarriage. Reprod Biomed Online 2006;13 1: 24–28.\nKitaya K, Yasuo T. Leukocyte density and composition in human cycling endometrium with uterine fibroids. Hum Immunol. 2010;71(2):158–163.\nAuthor information\nAuthors and Affiliations\nCorresponding author\nRights and permissions\nAbout this article\nCite this article\nMakker, A., Goel, M.M. Uterine Leiomyomas: Effects on Architectural, Cellular, and Molecular Determinants of Endometrial Receptivity. Reprod. Sci. 20, 631–638 (2013). https://doi.org/10.1177/1933719112459221\nPublished:\nIssue date:\nDOI: https://doi.org/10.1177/1933719112459221","source_license":"CC0","license_restricted":false}